Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $95 | 5 days | |
50 mg | $789 | 6-8 weeks | |
100 mg | $1,180 | 6-8 weeks |
Description | CDK5 inhibitor 20-223, a potent inhibitor of CDK2 and CDK5, demonstrates IC50 values of 6.0 nM and 8.8 nM, respectively. It serves as an effective agent against colorectal cancer (CRC)[1]. |
Targets&IC50 | CDK2:6.0 nM (IC50), CDK5:8.8 nM (IC50) |
In vitro | CDK5 inhibitor 20-223 (10 nM-10 μM; 72 hours) effectively inhibits cell growth in a range of colorectal cancer (CRC) cell lines. Additionally, CDK5 inhibitor 20-223 (0.3125-20 μM; 6 hours) induces a dose-dependent decrease in pRB (S807/811) and pFAK (S732) levels in CRC cell lines SW620, DLD1, HT29, HCT116, FET, CBS, and GEO. [1] Cell Viability Assay[1] Cell Line: CRC cell lines SW620, DLD1, HT29, HCT116, FET, CBS, and GEO cells. |
In vivo | CDK5 inhibitor 20-223 (8mg/kg; subcutaneously; for 14 injections) demonstrates anti-tumor activity in human CRC xenograft tumors in athymic nude mice[1]. |
Alias | CDK5 inhibitor 20-223 |
Molecular Weight | 305.37 |
Formula | C19H19N3O |
Cas No. | 865317-30-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.